Teladoc (TDOC) Tops Q4 EPS, Revenues; Provides Mixed Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Wall st set to open higher as chip stocks gain; US-Iran tensions in focus
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil eases as investors assess US-Iran peace prospects
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
Teladoc Health Reports Fourth Quarter and Full Year 2021 Results
February 22, 2022 4:05 PM ESTFourth quarter revenue grows 45% year-over-year to $554.2 million and total visits increase 41% to 4.4 million Full year revenue grows 86% year-over-year to $2,032.7 million and total visits increase 38% to 15.4 millionFull year cash flows from operations grew to $194.0 millionFull year 2022 Revenue guidance of $2.55 to $2.65 billion, representing 25% to 30% growth
PURCHASE, NY, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the fourth quarter and full year ended December 31, 2021. Â
Teladoc Health took a huge step forward in bringing true whole-person... More
